1. Home
  2. WHD vs AXSM Comparison

WHD vs AXSM Comparison

Compare WHD & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cactus Inc.

WHD

Cactus Inc.

HOLD

Current Price

$43.89

Market Cap

2.9B

Sector

Industrials

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$147.56

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHD
AXSM
Founded
2011
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
5.9B
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
WHD
AXSM
Price
$43.89
$147.56
Analyst Decision
Buy
Strong Buy
Analyst Count
5
20
Target Price
$49.20
$176.00
AVG Volume (30 Days)
594.3K
495.6K
Earning Date
10-29-2025
11-03-2025
Dividend Yield
1.28%
N/A
EPS Growth
N/A
N/A
EPS
2.52
N/A
Revenue
$1,089,969,000.00
$561,263,000.00
Revenue This Year
N/A
$66.20
Revenue Next Year
$33.92
$57.56
P/E Ratio
$17.37
N/A
Revenue Growth
N/A
65.83
52 Week Low
$33.20
$75.56
52 Week High
$65.35
$152.94

Technical Indicators

Market Signals
Indicator
WHD
AXSM
Relative Strength Index (RSI) 51.30 55.04
Support Level $45.17 $144.13
Resistance Level $48.83 $149.13
Average True Range (ATR) 1.51 4.21
MACD -0.05 -0.84
Stochastic Oscillator 31.13 50.77

Price Performance

Historical Comparison
WHD
AXSM

About WHD Cactus Inc.

Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. The company has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: